Nuclear factor ‘kappa-light-chain-enhancer’ of activated B cells (NFκB) regulates the expression of a variety of immunity- and inflammation-related genes and was identified as molecular target of helenalin in the T leukemia line Jurkat (5). This evidence concerns the gene NFKB1 and leukemia.